CN110177561B - 益生菌组合物和其用途 - Google Patents

益生菌组合物和其用途 Download PDF

Info

Publication number
CN110177561B
CN110177561B CN201880006818.0A CN201880006818A CN110177561B CN 110177561 B CN110177561 B CN 110177561B CN 201880006818 A CN201880006818 A CN 201880006818A CN 110177561 B CN110177561 B CN 110177561B
Authority
CN
China
Prior art keywords
cells
lactobacillus
probiotic
celiac disease
children
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880006818.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN110177561A (zh
Inventor
D·阿加德
I·拉佐阿伦
L·N·拉尔森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Probi AB
Original Assignee
Probi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1700542.2A external-priority patent/GB201700542D0/en
Priority claimed from GBGB1709731.2A external-priority patent/GB201709731D0/en
Application filed by Probi AB filed Critical Probi AB
Publication of CN110177561A publication Critical patent/CN110177561A/zh
Application granted granted Critical
Publication of CN110177561B publication Critical patent/CN110177561B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201880006818.0A 2017-01-12 2018-01-12 益生菌组合物和其用途 Active CN110177561B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1700542.2A GB201700542D0 (en) 2017-01-12 2017-01-12 Probiotic compositions and uses thereof
GB1700542.2 2017-01-12
GBGB1709731.2A GB201709731D0 (en) 2017-06-19 2017-06-19 Probiotic compositions and uses thereof
GB1709731.2 2017-06-19
PCT/EP2018/050789 WO2018130667A1 (en) 2017-01-12 2018-01-12 Probiotic compositions and uses thereof

Publications (2)

Publication Number Publication Date
CN110177561A CN110177561A (zh) 2019-08-27
CN110177561B true CN110177561B (zh) 2023-09-12

Family

ID=61386800

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880006818.0A Active CN110177561B (zh) 2017-01-12 2018-01-12 益生菌组合物和其用途

Country Status (14)

Country Link
US (1) US11166993B2 (https=)
EP (1) EP3568144B1 (https=)
JP (1) JP7089523B2 (https=)
KR (1) KR102500496B1 (https=)
CN (1) CN110177561B (https=)
AU (1) AU2018207946B2 (https=)
BR (1) BR112019014418A2 (https=)
CA (1) CA3049624A1 (https=)
CL (1) CL2019001938A1 (https=)
MX (1) MX2019008292A (https=)
MY (1) MY195253A (https=)
PH (1) PH12019501629A1 (https=)
RU (1) RU2763311C2 (https=)
WO (1) WO2018130667A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112584848A (zh) * 2018-06-18 2021-03-30 普罗比公司 益生菌组合物及其用途
IT201900014550A1 (it) * 2019-08-09 2021-02-09 Abiogen Pharma Spa Uso di colecalciferolo come agente attivo nel trattamento della celiachia
CN116869141A (zh) * 2022-05-05 2023-10-13 内蒙古一康健康发展有限责任公司 一种具有保健功能的益生菌复合物及其制备方法
KR102845919B1 (ko) * 2023-02-28 2025-08-14 주식회사 피엘비앤비 장내 유해세균의 성장 억제 성능이 우수한 한국인 모유 유래 락티카제이바실러스 파라카제이 pl1536 및 이를 유효성분으로 포함하는 기능성식품 조성물
CN119279210A (zh) * 2024-12-16 2025-01-10 山东健源生物科技有限公司 一种复合益生菌发酵含药食同源物质的多谷物后生元制剂及其制备方法和应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
WO2007108763A1 (en) * 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
CN101325960A (zh) * 2005-10-06 2008-12-17 普罗比公司 乳酸杆菌用于治疗自身免疫性疾病的用途
EP2581461A1 (en) * 2011-10-14 2013-04-17 GenMont Biotech Incorporation Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases
CA2908051A1 (en) * 2013-04-03 2014-10-09 Probi Ab Probiotic strains for use in treatment or prevention of osteoporosis
WO2016083450A2 (en) * 2014-11-25 2016-06-02 Stichting Top Institute Food And Nutrition New probiotic and new biomarker

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
AU2006297896B2 (en) 2005-10-06 2011-12-08 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
DK1996696T3 (en) 2006-03-17 2017-03-20 Probi Ab Thermostable lactobacillus strains
CN102438643B (zh) 2008-11-30 2015-07-01 免疫桑特公司 用于治疗乳糜泻的组合物和方法
ES3010649T3 (en) 2012-06-18 2025-04-04 Heinz Co Brands H J Llc Gluten-related disorders

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
CN101325960A (zh) * 2005-10-06 2008-12-17 普罗比公司 乳酸杆菌用于治疗自身免疫性疾病的用途
WO2007108763A1 (en) * 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
EP2581461A1 (en) * 2011-10-14 2013-04-17 GenMont Biotech Incorporation Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases
CA2908051A1 (en) * 2013-04-03 2014-10-09 Probi Ab Probiotic strains for use in treatment or prevention of osteoporosis
WO2016083450A2 (en) * 2014-11-25 2016-06-02 Stichting Top Institute Food And Nutrition New probiotic and new biomarker

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
乳糜泻研究进展;袁娟丽;蒋旭;胡帅;高金燕;陈红兵;;食品安全质量检测学报(第11期);全文 *

Also Published As

Publication number Publication date
RU2763311C2 (ru) 2021-12-28
US20190358275A1 (en) 2019-11-28
WO2018130667A1 (en) 2018-07-19
EP3568144C0 (en) 2024-05-08
CL2019001938A1 (es) 2019-09-27
CA3049624A1 (en) 2018-07-19
AU2018207946A1 (en) 2019-07-25
AU2018207946B2 (en) 2024-07-18
RU2019121145A3 (https=) 2021-04-26
EP3568144A1 (en) 2019-11-20
RU2019121145A (ru) 2021-02-12
JP7089523B2 (ja) 2022-06-22
US11166993B2 (en) 2021-11-09
JP2020513780A (ja) 2020-05-21
EP3568144B1 (en) 2024-05-08
KR20190104568A (ko) 2019-09-10
BR112019014418A2 (pt) 2020-04-14
MX2019008292A (es) 2019-09-16
MY195253A (en) 2023-01-11
PH12019501629A1 (en) 2020-06-01
CN110177561A (zh) 2019-08-27
KR102500496B1 (ko) 2023-02-16

Similar Documents

Publication Publication Date Title
CN110177561B (zh) 益生菌组合物和其用途
Miyazawa et al. Heat-killed Lactobacillus gasseri can enhance immunity in the elderly in a double-blind, placebo-controlled clinical study
JP6182628B2 (ja) 免疫疾患の処置において使用するための、プロバイオティック細菌を含む組成物
EP4014982B1 (en) Composition for inducing proliferation or accumulation of regulatory t cells
RU2440123C2 (ru) Применение lactobacillus для лечения вирусных инфекций
Marcial et al. Lactobacillus johnsonii N6. 2 modulates the host immune responses: a double-blind, randomized trial in healthy adults
Hirose et al. Daily intake of heat-killed Lactobacillus plantarum L-137 augments acquired immunity in healthy adults
Plaza-Diaz et al. Safety and immunomodulatory effects of three probiotic strains isolated from the feces of breast-fed infants in healthy adults: SETOPROB study
EP2598155A2 (en) Use of blood group status iii
US20150104423A1 (en) Use of blood group status iii
US10226492B2 (en) Probiotic and new biomarker
KR101234435B1 (ko) 면역 부활용 조성물
AU2020299976B2 (en) Serpin production
HK40075389B (en) Composition for inducing proliferation or accumulation of regulatory t cells
Korra et al. Trust Your Gut: The Human Gut Microbiome in Health and Disease
Pozo-Rubio et al. Pozo-Rubio T et al. Br J Nutr. 2011 Oct; 106 (8): 1216-23
Linker Aus dem Lehrstuhl für Neurologie Prof. Dr. med. Ralf Linker der Fakultät für Medizin der Universität Regensburg

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant